← All trials
NCT02589782
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 1, 2017
- Primary completion
- Jun 1, 2020
- Completion date
- Mar 1, 2021
- First posted
- —
- Last posted
- —
- Enrollment
- 630
- Arms / groups
- 4 / —
- Source
- AACT · pre-existing
Sponsors
- Medecins Sans FrontieresLead sponsor
- Global Alliance for TB Drug DevelopmentCollaborator
- World Health OrganizationCollaborator
- University of LondonCollaborator
- TB & HIV Investigative Network (THINK)Collaborator
- Drugs for Neglected Diseases InitiativeCollaborator
- Government of BelarusCollaborator
- Government of UzbekistanCollaborator
- University of BaselCollaborator
- ERT ClinicalCollaborator
- Medecins Sans FrontieresOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.